8-K Announcements
6Material company update
Feb 27, 2026·SEC
Material company update
Feb 17, 2026·SEC
Material company update
Feb 13, 2026·SEC
National HealthCare Corporation(NHC)Earnings, Financials & Key Ratios
NHC•AMEX
$169.41
$2.63B mkt cap·22.1× P/E·Price updated May 6, 2026
AboutNational HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and a behavioral health hospital. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living centers offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. It also offers behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, it provides health care programs that offer skilled services, such as infusion, wound care and physical, occupational, and speech therapies; hospice care services; operates pharmacies; offers management, accounting, financial, and insurance services; and leases its properties to third party operators. As of February 18, 2022, the company operated 75 skilled nursing facilities with 9,473 beds, 24 assisted living facilities, five independent living facilities, one behavioral health hospital, 34 homecare agencies, and 28 hospice agencies. National HealthCare Corporation was founded in 1971 and is based in Murfreesboro, Tennessee.Show more
- Revenue$1.47B+13.2%
- EBITDA$173M+35.6%
- Net Income$120M+17.7%
- EPS (Diluted)7.67+17.5%
- Gross Margin37.33%-0.5%
- EBITDA Margin11.79%+19.8%
- Operating Margin8.73%+32.2%
- Net Margin8.17%+4.0%
- ROE11.67%+8.4%
- ROIC8.43%+32.3%
- Debt/Equity0.08-62.9%
NHC Key Insights
National HealthCare Corporation (NHC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y profit CAGR of 23.4%
- ✓12 consecutive years of dividend growth
- ✓Momentum leader: RS Rating 82 (top 18%)
- ✓High quality earnings: Operating CF exceeds net income
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
NHC Price & Volume
National HealthCare Corporation (NHC) stock price & volume — 10-year historical chart
Loading chart...
NHC Growth Metrics
National HealthCare Corporation (NHC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years4.95%
5 Years8.43%
3 Years11.01%
TTM22.05%
Profit CAGR
10 Years8.49%
5 Years23.44%
3 Years74.87%
TTM-18.51%
EPS CAGR
10 Years9.14%
5 Years23.04%
3 Years74.24%
TTM-18.8%
Return on Capital
10 Years5.6%
5 Years5.67%
3 Years6.96%
Last Year8.43%
NHC Recent Earnings
National HealthCare Corporation (NHC) EPS & revenue vs analyst estimates — last 4 quarters
Q1 2026Latest
Feb 26, 2026EPS
$1.83
Revenue
$385M
Q4 2025
Nov 7, 2025EPS
$1.58
Revenue
$383M
Q3 2025
Aug 8, 2025EPS
$1.65
Revenue
$373M
Q2 2025
May 9, 2025EPS
$1.59
Revenue
$374M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 26, 2026 | $1.83 | $385M |
| Q4 2025 | Nov 7, 2025 | $1.58 | $383M |
| Q3 2025 | Aug 8, 2025 | $1.65 | $373M |
| Q2 2025 | May 9, 2025 | $1.59 | $374M |
Based on last 12 quarters of dataView full earnings history →
NHC Peer Comparison
National HealthCare Corporation (NHC) competitors in Post-acute and senior care — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 EHC | 10.45B | 105.16 | 18.98 | 10.46% | 10.04% | 18.86% | 4.2% | 0.83 |
 PNTG | 1.1B | 31.46 | 37.45 | 36.31% | 3.12% | 7.9% | 4.4% | 1.21 |
 ADUS | 1.84B | 98.44 | 18.89 | 23.21% | 6.89% | 9.34% | 5.66% | 0.19 |
 CCRN | 344.4M | 10.67 | -3.64 | -21.56% | -9% | -24.3% | 14.01% | 0.01 |
 SEM | 2.04B | 16.44 | 13.93 | 5.12% | 2.42% | 6.57% | 18.77% | 1.82 |
 SGRY | 1.85B | 14.26 | -23.38 | 6.24% | -2.28% | -2.39% | 10.6% | 1.14 |
 CHE | 5.85B | 427.55 | 23.21 | 4.06% | 10.23% | 25.33% | 5.57% | 0.16 |
 HCSG | 1.56B | 21.73 | 26.83 | 7.08% | 3.21% | 11.83% | 8.94% | 0.05 |
Compare NHC vs Peers
National HealthCare Corporation (NHC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NHC Income Statement
National HealthCare Corporation (NHC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 963.89M | 980.35M | 996.38M | 980.71M | 1.01B | 1.07B | 1.14B | 1.3B | 1.47B | 1.5B |
| Revenue Growth % | 4.37% | 1.71% | 1.64% | -1.57% | 3.08% | 6.27% | 6.26% | 13.7% | 13.23% | 22.05% |
| Cost of Goods Sold | 572.04M | 582.72M | 592.83M | 609.31M | 666.06M | 686.17M | 712.34M | 810.93M | 921.08M | 922.16M |
| COGS % of Revenue | 59.35% | 59.44% | 59.5% | 62.13% | 65.89% | 63.87% | 62.4% | 62.48% | 62.67% | - |
| Gross Profit | 391.85M▲ 0% | 397.63M▲ 1.5% | 403.55M▲ 1.5% | 371.41M▼ 8.0% | 344.88M▼ 7.1% | 388.11M▲ 12.5% | 429.2M▲ 10.6% | 487.01M▲ 13.5% | 548.55M▲ 12.6% | 578.46M▲ 0% |
| Gross Margin % | 40.65% | 40.56% | 40.5% | 37.87% | 34.11% | 36.13% | 37.6% | 37.52% | 37.33% | 38.55% |
| Gross Profit Growth % | 4.33% | 1.47% | 1.49% | -7.97% | -7.14% | 12.54% | 10.59% | 13.47% | 12.64% | - |
| Operating Expenses | 337.74M | 341.55M | 354.51M | 323.25M | 293.95M | 356.22M | 372.07M | 401.25M | 468.35M | 456.66M |
| OpEx % of Revenue | 35.04% | 34.84% | 35.58% | 32.96% | 29.08% | 33.16% | 32.59% | 30.91% | 31.87% | - |
| Selling, General & Admin | 40.37M | 40.92M | 40.52M | 40.49M | 40.82M | 40.98M | 41.52M | 43.18M | 0 | 65.84M |
| SG&A % of Revenue | 4.19% | 4.17% | 4.07% | 4.13% | 4.04% | 3.81% | 3.64% | 3.33% | - | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 297.38M | 300.63M | 314M | 282.76M | 253.14M | 315.24M | 330.54M | 358.06M | 468.35M | 4M |
| Operating Income | 54.11M▲ 0% | 56.08M▲ 3.6% | 49.04M▼ 12.6% | 48.16M▼ 1.8% | 50.92M▲ 5.8% | 31.9M▼ 37.4% | 57.13M▲ 79.1% | 85.76M▲ 50.1% | 128.35M▲ 49.7% | 121.8M▲ 0% |
| Operating Margin % | 5.61% | 5.72% | 4.92% | 4.91% | 5.04% | 2.97% | 5% | 6.61% | 8.73% | 8.12% |
| Operating Income Growth % | -10.62% | 3.63% | -12.55% | -1.8% | 5.75% | -37.37% | 79.13% | 50.1% | 49.66% | - |
| EBITDA | 96.76M | 97.97M | 91.46M | 90.17M | 91.6M | 72.39M | 99.17M | 127.75M | 173.27M | 166.39M |
| EBITDA Margin % | 10.04% | 9.99% | 9.18% | 9.19% | 9.06% | 6.74% | 8.69% | 9.84% | 11.79% | 11.09% |
| EBITDA Growth % | -2.82% | 1.25% | -6.65% | -1.4% | 1.58% | -20.97% | 37% | 28.82% | 35.64% | 36.81% |
| D&A (Non-Cash Add-back) | 42.65M | 41.89M | 42.42M | 42.02M | 40.67M | 40.49M | 42.03M | 41.98M | 44.92M | 44.59M |
| EBIT | 79.44M | 79.58M | 91.15M | 53.82M | 150.88M | 27.79M | 89.06M | 140.54M | 0 | 144.26M |
| Net Interest Income | 1.28M | 2.49M | 4.05M | 4.4M | 3.82M | 4.57M | 8.06M | 5.97M | 0 | 1.12M |
| Interest Income | 6.17M | 7.18M | 7.19M | 5.79M | 4.67M | 5.13M | 8.38M | 10.1M | 0 | 7.03M |
| Interest Expense | 4.89M | 4.7M | 3.13M | 1.4M | 845K | 563K | 324K | 4.13M | -6.37M | 5.91M |
| Other Income/Expense | 20.44M | 18.81M | 38.98M | 4.27M | 99.11M | -4.67M | 31.6M | 50.65M | 34.08M | 14.56M |
| Pretax Income | 74.55M▲ 0% | 74.88M▲ 0.4% | 88.02M▲ 17.5% | 52.42M▼ 40.4% | 150.04M▲ 186.2% | 27.23M▼ 81.9% | 88.74M▲ 225.9% | 136.41M▲ 53.7% | 162.43M▲ 19.1% | 136.36M▲ 0% |
| Pretax Margin % | 7.73% | 7.64% | 8.83% | 5.35% | 14.84% | 2.53% | 7.77% | 10.51% | 11.05% | 9.09% |
| Income Tax | 18.87M | 16.18M | 20.04M | 10.43M | 10.95M | 7.25M | 23.45M | 34.32M | -39.83M | 32.91M |
| Effective Tax Rate % | 25.31% | 21.61% | 22.77% | 19.9% | 7.3% | 26.64% | 26.43% | 25.16% | -24.52% | 24.14% |
| Net Income | 56.2M▲ 0% | 58.96M▲ 4.9% | 68.21M▲ 15.7% | 41.87M▼ 38.6% | 138.59M▲ 231.0% | 22.45M▼ 83.8% | 66.8M▲ 197.6% | 101.93M▲ 52.6% | 120.02M▲ 17.7% | 101.25M▲ 0% |
| Net Margin % | 5.83% | 6.01% | 6.85% | 4.27% | 13.71% | 2.09% | 5.85% | 7.85% | 8.17% | 6.75% |
| Net Income Growth % | 11.21% | 4.91% | 15.68% | -38.62% | 230.99% | -83.8% | 197.61% | 52.59% | 17.75% | -18.51% |
| Net Income (Continuing) | 55.68M | 58.7M | 67.98M | 41.99M | 139.09M | 19.98M | 65.29M | 102.09M | 120.02M | 103.44M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 694K | 1.18M | 476K | 3.08M | 5.46M | 3.24M | 1.73M | 3M | 5.74M | 5.25M |
| EPS (Diluted) | 3.69▲ 0% | 3.87▲ 4.9% | 4.44▲ 14.7% | 2.72▼ 38.7% | 8.99▲ 230.5% | 1.45▼ 83.9% | 4.34▲ 199.3% | 6.53▲ 50.5% | 7.67▲ 17.5% | 6.46▲ 0% |
| EPS Growth % | 11.14% | 4.88% | 14.73% | -38.74% | 230.51% | -83.87% | 199.31% | 50.46% | 17.46% | -18.8% |
| EPS (Basic) | 3.70 | 3.87 | 4.47 | 2.74 | 9.03 | 1.46 | 4.36 | 6.62 | 7.76 | - |
| Diluted Shares Outstanding | 15.22M | 15.24M | 15.36M | 15.37M | 15.42M | 15.45M | 15.38M | 15.6M | 15.65M | 15.66M |
| Basic Shares Outstanding | 15.19M | 15.22M | 15.27M | 15.31M | 15.35M | 15.41M | 15.31M | 15.39M | 15.47M | 15.48M |
| Dividend Payout Ratio | 50.24% | 50.59% | 45.75% | 76.24% | 23.11% | 154.17% | 53.24% | 36.27% | - | - |
NHC Balance Sheet
National HealthCare Corporation (NHC) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 329.31M | 322.01M | 341.05M | 456.75M | 426.64M | 353.93M | 406.24M | 424.41M | 0 | 493.52M |
| Cash & Short-Term Investments | 198.2M | 183.47M | 202.79M | 323.44M | 256.02M | 182.59M | 223.62M | 216.19M | 0 | 297.38M |
| Cash Only | 198.2M | 183.47M | 50.33M | 147.09M | 107.61M | 58.67M | 107.08M | 76.12M | 0 | 130.63M |
| Short-Term Investments | 0 | 0 | 152.45M | 176.35M | 148.42M | 123.92M | 116.54M | 140.06M | 0 | 166.75M |
| Accounts Receivable | 93.68M | 98.56M | 91.32M | 89.67M | 96.58M | 100.29M | 109.05M | 135.84M | 0 | 132.45M |
| Days Sales Outstanding | 35.47 | 36.7 | 33.45 | 33.37 | 34.87 | 34.07 | 34.87 | 38.2 | - | 33.6 |
| Inventory | 7.15M | 7.47M | 7.44M | 8.78M | 8.58M | 7.09M | 7.39M | 9.04M | 0 | 7.84M |
| Days Inventory Outstanding | 4.56 | 4.68 | 4.58 | 5.26 | 4.7 | 3.77 | 3.78 | 4.07 | - | 3.25 |
| Other Current Assets | 27.41M | 28.64M | 32.87M | 30.95M | 58.09M | 63.97M | 66.18M | 63.35M | 0 | 49.97M |
| Total Non-Current Assets | 767.22M | 758.94M | 945.6M | 905.38M | 976.76M | 921.52M | 904.56M | 1.1B | 0 | 1.08B |
| Property, Plant & Equipment | 549.32M | 534.65M | 738.34M | 699.37M | 677.11M | 627.05M | 587.53M | 763.46M | 0 | 730.99M |
| Fixed Asset Turnover | 1.75x | 1.83x | 1.35x | 1.40x | 1.49x | 1.71x | 1.94x | 1.70x | - | 2.01x |
| Goodwill | 17.6M | 21M | 21M | 21.34M | 168.29M | 168.29M | 168.29M | 170.48M | 0 | 170.48M |
| Intangible Assets | 0 | 0 | 0 | 0 | 7.04M | 7.04M | 7.04M | 19.86M | 0 | 19.86M |
| Long-Term Investments | 36.34M | 32.36M | 39.19M | 40.78M | 2.02M | 2.06M | 16.27M | 27.88M | 0 | 131.4M |
| Other Non-Current Assets | 145.58M | 152.38M | 147.07M | 143.88M | 122.29M | 117.07M | 125.43M | 118.34M | 0 | 494.16M |
| Total Assets | 1.1B▲ 0% | 1.08B▼ 1.4% | 1.29B▲ 19.0% | 1.36B▲ 5.9% | 1.4B▲ 3.0% | 1.28B▼ 9.1% | 1.31B▲ 2.8% | 1.52B▲ 16.3% | 0▼ 100.0% | 1.57B▲ 0% |
| Asset Turnover | 0.88x | 0.91x | 0.77x | 0.72x | 0.72x | 0.84x | 0.87x | 0.85x | - | 0.97x |
| Asset Growth % | 0.83% | -1.42% | 19.03% | 5.87% | 3.03% | -9.12% | 2.77% | 16.3% | -100% | 50.88% |
| Total Current Liabilities | 155.06M | 157.92M | 194.76M | 281.23M | 263.2M | 197.89M | 214.48M | 234.8M | 253.63M | 282.36M |
| Accounts Payable | 15.98M | 19.76M | 18.9M | 21.11M | 22.49M | 16.96M | 19.19M | 25.49M | 22.77M | 22.57M |
| Days Payables Outstanding | 10.2 | 12.38 | 11.64 | 12.65 | 12.32 | 9.02 | 9.83 | 11.47 | 9.02 | 9 |
| Short-Term Debt | 3.7M | 3.92M | 10M | 0 | 0 | 0 | 0 | 7.5M | 41.11M | 7.5M |
| Deferred Revenue (Current) | 3.23M | 3.05M | 0 | 67.32M | 24.46M | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 39.91M | 38.97M | 15.03M | 21.34M | 20.06M | 17.61M | 22.99M | 21.38M | 212.52M | 109.1M |
| Current Ratio | 2.12x | 2.04x | 1.75x | 1.62x | 1.62x | 1.79x | 1.89x | 1.81x | - | 1.75x |
| Quick Ratio | 2.08x | 1.99x | 1.71x | 1.59x | 1.59x | 1.75x | 1.86x | 1.77x | - | 1.72x |
| Cash Conversion Cycle | 29.84 | 29 | 26.4 | 25.99 | 27.25 | 28.82 | 28.82 | 30.79 | - | 27.85 |
| Total Non-Current Liabilities | 238.72M | 189.75M | 312.82M | 282.64M | 231.74M | 200.05M | 185.84M | 306.47M | 198.27M | 231.56M |
| Long-Term Debt | 100M | 55M | 0 | 0 | 0 | 0 | 0 | 129.5M | 45.96M | 65.63M |
| Capital Lease Obligations | 23.05M | 19.13M | 193.63M | 164.14M | 134.39M | 91.88M | 63.17M | 45.92M | 0 | 134.37M |
| Deferred Tax Liabilities | 18.38M | 18.55M | 24.01M | 14.08M | 6.85M | 10.91M | 17.2M | 35.55M | 42.69M | 107.3M |
| Other Non-Current Liabilities | 114.98M | 114.44M | 90M | 104.42M | 90.5M | 97.26M | 105.47M | 95.49M | 109.62M | 441.94M |
| Total Liabilities | 393.79M | 347.67M | 507.58M | 563.87M | 494.94M | 397.94M | 400.32M | 541.27M | 451.9M | 513.91M |
| Total Debt | 126.75M | 78.05M | 232.04M | 194.02M | 166.66M | 125.94M | 93.39M | 214.77M | 87.07M | 128.07M |
| Net Debt | -71.45M | -105.42M | 181.7M | 46.92M | 59.05M | 67.27M | -13.69M | 138.65M | 87.07M | -2.56M |
| Debt / Equity | 0.18x | 0.11x | 0.30x | 0.24x | 0.18x | 0.14x | 0.10x | 0.22x | 0.08x | 0.08x |
| Debt / EBITDA | 1.31x | 0.80x | 2.54x | 2.15x | 1.82x | 1.74x | 0.94x | 1.68x | 0.50x | 0.77x |
| Net Debt / EBITDA | -0.74x | -1.08x | 1.99x | 0.52x | 0.64x | 0.93x | -0.14x | 1.09x | 0.50x | 0.50x |
| Interest Coverage | 11.07x | 11.94x | 15.64x | 34.42x | 60.27x | 56.65x | 176.34x | 20.74x | - | 24.41x |
| Total Equity | 703.43M▲ 0% | 734.46M▲ 4.4% | 779.07M▲ 6.1% | 798.26M▲ 2.5% | 908.46M▲ 13.8% | 877.51M▼ 3.4% | 910.48M▲ 3.8% | 983.16M▲ 8.0% | 1.07B▲ 9.3% | 1.06B▲ 0% |
| Equity Growth % | 11.73% | 4.41% | 6.07% | 2.46% | 13.8% | -3.41% | 3.76% | 7.98% | 9.29% | 32.2% |
| Book Value per Share | 46.22 | 48.20 | 50.72 | 51.94 | 58.93 | 56.81 | 59.21 | 63.03 | 68.68 | 67.56 |
| Total Shareholders' Equity | 702.74M | 733.28M | 778.59M | 795.18M | 903M | 874.28M | 908.75M | 980.16M | 1.07B | 1.05B |
| Common Stock | 152K | 153K | 153K | 153K | 154K | 153K | 153K | 154K | 155K | 154K |
| Retained Earnings | 419.42M | 516.43M | 553.09M | 563.02M | 669.08M | 656.66M | 687.6M | 752.19M | 832.98M | 818.08M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 67.5M | -2.75M | 2.56M | 5.06M | 1.6M | -9.53M | -6.6M | -4.72M | -779K | -1.13M |
| Minority Interest | 694K | 1.18M | 476K | 3.08M | 5.46M | 3.24M | 1.73M | 3M | 5.74M | 5.25M |
NHC Cash Flow Statement
National HealthCare Corporation (NHC) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 94.47M | 98.44M | 100.1M | 203.26M | 62.39M | 8.74M | 111.22M | 107.3M | 185.08M | 185.08M |
| Operating CF Margin % | 9.8% | 10.04% | 10.05% | 20.73% | 6.17% | 0.81% | 9.74% | 8.27% | 12.59% | - |
| Operating CF Growth % | 3.94% | 4.2% | 1.69% | 103.05% | -69.3% | -85.99% | 1172.2% | -3.52% | 72.48% | 602.75% |
| Net Income | 55.68M | 58.7M | 67.98M | 41.99M | 139.09M | 19.98M | 65.29M | 102.09M | 122.61M | 101.25M |
| Depreciation & Amortization | 42.65M | 41.89M | 42.42M | 42.02M | 40.67M | 40.49M | 42.03M | 41.98M | 44.92M | 44.59M |
| Stock-Based Compensation | 1.68M | 1.78M | 1.88M | 2.45M | 2.62M | 2.61M | 2.78M | 4.16M | 4.4M | 4.6M |
| Deferred Taxes | -4.71M | 718K | 4.05M | -10.59M | -6.29M | 6M | 5.77M | 17.94M | 6.48M | 4.98M |
| Other Non-Cash Items | 5.89M | -653K | -20.17M | 16.99M | -72.95M | 13.37M | -22.05M | -33.15M | 6.68M | -6.55M |
| Working Capital Changes | -6.72M | -4M | 3.95M | 110.4M | -40.74M | -73.7M | 17.4M | -25.72M | 0 | 30M |
| Change in Receivables | -9.49M | -9.4M | 4.3M | 4.53M | 4.09M | -3.86M | -8.56M | -26.44M | -3.68M | -3.67M |
| Change in Inventory | 355K | -317K | 29K | -1.25M | 199K | 1.49M | -298K | -599K | 1.24M | -2K |
| Change in Payables | -2.62M | 3.47M | -856K | 1.43M | -2.08M | -5.53M | 2.24M | 6.3M | -2.73M | -157K |
| Cash from Investing | -9.56M | -33.66M | -14.27M | -63.88M | -65.89M | -5.98M | -17.57M | -236.69M | -33.86M | -32.57M |
| Capital Expenditures | -32.35M | -29.77M | -26.4M | -21.87M | -39.4M | -30.2M | -27.9M | -27.6M | -36.45M | -34.2M |
| CapEx % of Revenue | 3.36% | 3.04% | 2.65% | 2.23% | 3.9% | 2.81% | 2.44% | 2.13% | 2.48% | - |
| Acquisitions | -246K | 3.33M | -15.81M | -203K | -29.06M | 0 | -7.36M | -228.1M | 0 | -11.15M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 4.08M | 1.55M | -4.08M | 2.06M | 8.84M | 8.05M | -201K | 2.09M | -3.95M | 3.18M |
| Cash from Financing | -49.07M | -77.27M | -79.75M | -41.89M | -35.26M | -47.64M | -42.55M | 100.34M | -135.96M | -112.03M |
| Debt Issued (Net) | -23.48M | -48.7M | -48.92M | -14.17M | -4.42M | -4.7M | -4.99M | 136.14M | 0 | -73.88M |
| Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | -1000K | 766K | 0 | 646K |
| Dividends Paid | -28.24M | -29.83M | -31.21M | -31.92M | -32.03M | -34.6M | -35.56M | -36.96M | -38.7M | -38.19M |
| Share Repurchases | 0 | -867K | -872K | -53K | -836K | -9.9M | -2.48M | -13.5M | -14.73M | -9.57M |
| Other Financing | 120K | -749K | -1.09M | 2.5M | -1.42M | -554K | 169K | 402K | -97.25M | -610K |
| Net Change in Cash | 35.83M▲ 0% | -12.5M▼ 134.9% | 6.09M▲ 148.7% | 97.49M▲ 1500.9% | -38.76M▼ 139.8% | -44.88M▼ 15.8% | 51.1M▲ 213.9% | -29.05M▼ 156.8% | 15.27M▲ 152.6% | 36.46M▲ 0% |
| Free Cash Flow | 62.12M▲ 0% | 68.66M▲ 10.5% | 73.7M▲ 7.3% | 181.39M▲ 146.1% | 23M▼ 87.3% | -21.46M▼ 193.3% | 83.31M▲ 488.3% | 79.7M▼ 4.3% | 148.63M▲ 86.5% | 146.85M▲ 0% |
| FCF Margin % | 6.44% | 7% | 7.4% | 18.5% | 2.27% | -2% | 7.3% | 6.14% | 10.11% | 9.79% |
| FCF Growth % | 119.65% | 10.53% | 7.34% | 146.1% | -87.32% | -193.32% | 488.27% | -4.34% | 86.48% | 99.32% |
| FCF per Share | 4.08 | 4.51 | 4.80 | 11.80 | 1.49 | -1.39 | 5.42 | 5.11 | 9.50 | 9.50 |
| FCF Conversion (FCF/Net Income) | 1.68x | 1.67x | 1.47x | 4.85x | 0.45x | 0.39x | 1.66x | 1.05x | 1.54x | 1.45x |
| Interest Paid | 5.18M | 4.9M | 3.12M | 1.43M | 845K | 493K | 290K | 3.42M | 0 | 0 |
| Taxes Paid | 23.55M | 9.18M | 20.89M | 16.52M | 22.88M | 8.77M | 14.57M | 17.52M | 0 | 0 |
NHC Key Ratios
National HealthCare Corporation (NHC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 8.43% | 8.2% | 9.01% | 5.31% | 16.24% | 2.51% | 7.47% | 10.77% | 11.67% | 9.57% |
| Return on Invested Capital (ROIC) | 5.86% | 6.67% | 4.63% | 4% | 4.21% | 2.5% | 4.65% | 6.37% | 8.43% | 8.43% |
| Gross Margin | 40.65% | 40.56% | 40.5% | 37.87% | 34.11% | 36.13% | 37.6% | 37.52% | 37.33% | 38.55% |
| Net Margin | 5.83% | 6.01% | 6.85% | 4.27% | 13.71% | 2.09% | 5.85% | 7.85% | 8.17% | 6.75% |
| Debt / Equity | 0.18x | 0.11x | 0.30x | 0.24x | 0.18x | 0.14x | 0.10x | 0.22x | 0.08x | 0.08x |
| Interest Coverage | 11.07x | 11.94x | 15.64x | 34.42x | 60.27x | 56.65x | 176.34x | 20.74x | - | 24.41x |
| FCF Conversion | 1.68x | 1.67x | 1.47x | 4.85x | 0.45x | 0.39x | 1.66x | 1.05x | 1.54x | 1.45x |
| Revenue Growth | 4.37% | 1.71% | 1.64% | -1.57% | 3.08% | 6.27% | 6.26% | 13.7% | 13.23% | 22.05% |
NHC SEC Filings & Documents
National HealthCare Corporation (NHC) SEC filings — annual & quarterly reports (10-K, 10-Q)
NHC Frequently Asked Questions
National HealthCare Corporation (NHC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
National HealthCare Corporation (NHC) reported $1.50B in revenue for fiscal year 2025. This represents a 288% increase from $386.3M in 1996.
National HealthCare Corporation (NHC) grew revenue by 13.2% over the past year. This is steady growth.
Yes, National HealthCare Corporation (NHC) is profitable, generating $101.2M in net income for fiscal year 2025 (8.2% net margin).
Dividend & Returns
Yes, National HealthCare Corporation (NHC) pays a dividend with a yield of 1.46%. This makes it attractive for income-focused investors.
National HealthCare Corporation (NHC) has a return on equity (ROE) of 11.7%. This is reasonable for most industries.
National HealthCare Corporation (NHC) generated $146.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More NHC
National HealthCare Corporation (NHC) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates